Allergy
Allergic rhinitis: treat early to reduce impact
Treating allergic rhinitis early in the allergy season with intranasal corticosteroids reduces its impact. By Dr Brett MacFarlane, PhD, BPharm (Hons), Chief Pharmacist, Australasian College of Pharmacy Learning objectives After …
Everyone appreciates choice
Patients don’t have a choice when it comes to allergies and the risk of anaphylaxis, but now you have a choice of treatment. Anaphylaxis is an acute, potentially lethal reaction, …
Research Roundup
Debbie Rigby rounds up the latest in research news Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation Supplementation with marine omega-3 fatty acids and/or …
Changing concepts: Allergic Rhinitis
The concept of how we manage allergic rhinitis in the community is shifting, thanks to a growing understanding of patients’ perceptions and behaviour regarding treatment Allergic rhinitis is a common …
Back to school matters: managing allergic rhinitis in children
ALLERGIC RHINITIS: PART 2 Emerging evidence suggests that allergic rhinitis can have a major impact on children’s daily activities and academic performance. A better understanding of the full impact of …
Environmental factors and allergic rhinitis
ALLERGIC RHINITIS: PART 1 This article discusses the importance of understanding environmental triggers as part of a shared decision-making approach to allergic rhinitis management in the pharmacy. By Professor Sinthia …
Allergic rhinitis: more than a sniffle & a sneeze
With the availability of over-the-counter treatments for allergy symptoms, many people choose to self-treat. Yet, often this results in sub-optimal management Several studies have shown that allergic rhinitis (hay fever) can …
Research Roundup
Debbie Rigby takes a look at the latest in research news Impact of Medication Regimen Simplification on Medication Administration Times and Health Outcomes in Residential Aged Care This 12 month …
Confusion reigns over EpiPen availability
Patient frustration at difficulty accessing EpiPens is understandable – but it’s unfair to call pharmacy “complacent,” says a leading pharmacist Allergy and Anaphylaxis Australia chief executive Maria Said has told …
Rise in meds use
The number of Australians taking cold, flu and allergy medication has risen by almost 3 million in a decade While the rate of Australians’ overall medication consumption has risen only …
Prepare for pollen
The National Asthma Council Australia is calling on healthcare professionals to mark National Asthma Week by preparing the millions of Australians with asthma for pollen season Launching today, the week …
Are PPIs affecting allergy?
A new analysis has found an association between taking prescription antacids and the risk of developing allergies A population-based analysis of health insurance records data for 8.2 million Austrians (97% …